List view / Grid view

Acacia Pharma



Acacia Pharma’s antiemetic drug prevents post-op nausea and vomiting

12 August 2016 | By Acacia Pharma

Acacia Pharma’s phase 3 trial, comprised of 568 patients, compared two doses of Baremsis (amisulpride injection, formerly APD421), a dopamine D2/D3 antagonist antiemetic, against placebo in patients with established nausea and/or vomiting after surgery (PONV), who had not previously received any prophylactic antiemetics...